Brochure | February 24, 2022

CHO Platform Service Package: The Fast Track To IND

Source: Sartorius

Uncompromised Quality and Robust Scalability for Biopharmaceutical Cell Line Development

Development of new protein therapeutics is a complex process, with technical and regulatory hurdles to overcome in the path to commercial success. With increasing competition and the progress of biosimilars, drug developers need to focus on speed, predictability, and quality.

The Sartorius CHO Platform service package brings together cell line development (CLD) including the fully optimized 4Cell® cell culture media system, protein characterization, cell banking, and biosafety testing to accelerate your program and puts your molecule on the path to success.

The package offers reduced costs and proven results while maintaining an exceptional degree of flexibility. With the freedom to use the CMO of your choice, you can rapidly progress from DNA to GMP cell bank (MCB | WCB) and overcome typical obstacles that can delay a first commercial manufacturing batch.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online